Search
Results: 1
The immunogenicity of midbrain dopaminergic neurons and the implications for neural grafting trials in Parkinson's disease.
Dopaminergic (DA) cell replacement therapies are a promising experimental treatment for Parkinson's disease (PD) and a number of different types of DA cell-based therapies have already been trialled in patients. To date, the...
Immunogenicity transplant immune rejection Parkinson’s disease dopaminergic human foetal ventral midbrain
Published by: Neuronal signaling